- Home
- ARVN vs EVLV Comparison
ARVN vs EVLV Comparison
Compare ARVN & EVLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- EVLV
- Stock Information
- Founded
- ARVN 2015
- EVLV 2013
- Country
- ARVN United States
- EVLV United States
- Employees
- ARVN N/A
- EVLV N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- EVLV Computer peripheral equipment
- Sector
- ARVN Health Care
- EVLV Technology
- Exchange
- ARVN Nasdaq
- EVLV Nasdaq
- Market Cap
- ARVN 614.8M
- EVLV 671.9M
- IPO Year
- ARVN 2018
- EVLV N/A
- Fundamental
- Price
- ARVN $6.13
- EVLV $4.41
- Analyst Decision
- ARVN Buy
- EVLV Strong Buy
- Analyst Count
- ARVN 19
- EVLV 4
- Target Price
- ARVN $21.14
- EVLV $5.31
- AVG Volume (30 Days)
- ARVN 3.3M
- EVLV 2.4M
- Earning Date
- ARVN 05-01-2025
- EVLV 05-20-2025
- Dividend Yield
- ARVN N/A
- EVLV N/A
- EPS Growth
- ARVN N/A
- EVLV N/A
- EPS
- ARVN N/A
- EVLV N/A
- Revenue
- ARVN $426,900,000.00
- EVLV $103,865,000.00
- Revenue This Year
- ARVN N/A
- EVLV $22.05
- Revenue Next Year
- ARVN N/A
- EVLV $21.26
- P/E Ratio
- ARVN N/A
- EVLV N/A
- Revenue Growth
- ARVN 498.74
- EVLV 30.54
- 52 Week Low
- ARVN $5.94
- EVLV $2.01
- 52 Week High
- ARVN $37.38
- EVLV $4.65
- Technical
- Relative Strength Index (RSI)
- ARVN 32.27
- EVLV 65.77
- Support Level
- ARVN $6.02
- EVLV $4.32
- Resistance Level
- ARVN $7.05
- EVLV $4.56
- Average True Range (ATR)
- ARVN 0.56
- EVLV 0.28
- MACD
- ARVN -0.12
- EVLV 0.02
- Stochastic Oscillator
- ARVN 2.87
- EVLV 76.81
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About EVLV Evolv Technologies Holdings Inc.
Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.